Effect of aromatase inhibitors on bone mineral density in a Japanese breast cancer population

Takeshi Akiyoshi, Yuka Shimomura, Shinichi Masuda, Yasushi Okamoto, Sumiko Hiura, Hiroyoshi Kato, Toru Asayama, Hisakazu Ohtani

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We retrospectively analyzed the bone mineral density (BMD) of postmenopausal Japanese women taking an aromatase inhibitor (AI), exemestane, anastrozole or letrozole, and calculated the decrease rate constant of BMD in each individual to compare the influence of the three AIs on BMD. We also aimed to evaluate the preventive effect of bisphosphonates (BPs) on the AI-induced decrease in BMD. The decrease rate constant of BMD (ke) in each individual was determined as a slope of linear regression of the relationship between time and logarithm of BMD value in each patient during the AI therapy. To compensate for the age-related change in BMD level, we estimated the age-related decrease rate constant of BMD (ke,0) in healthy Japanese postmenopausal women from the literature. AIs decreased BMD with a ke value of -0.0329 yr-1, which was 4.7-fold larger than the ke,0 value of -0.00699 yr-1. No significant difference was detected in the influence on BMD among AIs. Co-administration of BP ameliorated the ke value to -0.0117 yr-1, a value similar to ke,0. The influence of AIs on BMD was quantitatively evaluated by using the decrease rate constant of BMD (ke). The present study also suggests that BPs may be useful to prevent the decrease in BMD induced by AIs.

Original languageEnglish
Pages (from-to)446-450
Number of pages5
JournalDrug Metabolism and Pharmacokinetics
Volume28
Issue number5
DOIs
Publication statusPublished - 2013

Fingerprint

Aromatase Inhibitors
Bone Density
Breast Neoplasms
Population
Diphosphonates
exemestane
letrozole
Linear Models

Keywords

  • Aromatase inhibitor
  • Bisphosphonate
  • Bone mineral density
  • Postmenopausal Japanese population

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Pharmaceutical Science

Cite this

Effect of aromatase inhibitors on bone mineral density in a Japanese breast cancer population. / Akiyoshi, Takeshi; Shimomura, Yuka; Masuda, Shinichi; Okamoto, Yasushi; Hiura, Sumiko; Kato, Hiroyoshi; Asayama, Toru; Ohtani, Hisakazu.

In: Drug Metabolism and Pharmacokinetics, Vol. 28, No. 5, 2013, p. 446-450.

Research output: Contribution to journalArticle

Akiyoshi, Takeshi ; Shimomura, Yuka ; Masuda, Shinichi ; Okamoto, Yasushi ; Hiura, Sumiko ; Kato, Hiroyoshi ; Asayama, Toru ; Ohtani, Hisakazu. / Effect of aromatase inhibitors on bone mineral density in a Japanese breast cancer population. In: Drug Metabolism and Pharmacokinetics. 2013 ; Vol. 28, No. 5. pp. 446-450.
@article{146b1bd327594a209f14af9699ded75e,
title = "Effect of aromatase inhibitors on bone mineral density in a Japanese breast cancer population",
abstract = "We retrospectively analyzed the bone mineral density (BMD) of postmenopausal Japanese women taking an aromatase inhibitor (AI), exemestane, anastrozole or letrozole, and calculated the decrease rate constant of BMD in each individual to compare the influence of the three AIs on BMD. We also aimed to evaluate the preventive effect of bisphosphonates (BPs) on the AI-induced decrease in BMD. The decrease rate constant of BMD (ke) in each individual was determined as a slope of linear regression of the relationship between time and logarithm of BMD value in each patient during the AI therapy. To compensate for the age-related change in BMD level, we estimated the age-related decrease rate constant of BMD (ke,0) in healthy Japanese postmenopausal women from the literature. AIs decreased BMD with a ke value of -0.0329 yr-1, which was 4.7-fold larger than the ke,0 value of -0.00699 yr-1. No significant difference was detected in the influence on BMD among AIs. Co-administration of BP ameliorated the ke value to -0.0117 yr-1, a value similar to ke,0. The influence of AIs on BMD was quantitatively evaluated by using the decrease rate constant of BMD (ke). The present study also suggests that BPs may be useful to prevent the decrease in BMD induced by AIs.",
keywords = "Aromatase inhibitor, Bisphosphonate, Bone mineral density, Postmenopausal Japanese population",
author = "Takeshi Akiyoshi and Yuka Shimomura and Shinichi Masuda and Yasushi Okamoto and Sumiko Hiura and Hiroyoshi Kato and Toru Asayama and Hisakazu Ohtani",
year = "2013",
doi = "10.2133/dmpk.DMPK-12-NT-095",
language = "English",
volume = "28",
pages = "446--450",
journal = "Drug Metabolism and Pharmacokinetics",
issn = "1347-4367",
publisher = "Japanese Society for the Study of Xenobiotics",
number = "5",

}

TY - JOUR

T1 - Effect of aromatase inhibitors on bone mineral density in a Japanese breast cancer population

AU - Akiyoshi, Takeshi

AU - Shimomura, Yuka

AU - Masuda, Shinichi

AU - Okamoto, Yasushi

AU - Hiura, Sumiko

AU - Kato, Hiroyoshi

AU - Asayama, Toru

AU - Ohtani, Hisakazu

PY - 2013

Y1 - 2013

N2 - We retrospectively analyzed the bone mineral density (BMD) of postmenopausal Japanese women taking an aromatase inhibitor (AI), exemestane, anastrozole or letrozole, and calculated the decrease rate constant of BMD in each individual to compare the influence of the three AIs on BMD. We also aimed to evaluate the preventive effect of bisphosphonates (BPs) on the AI-induced decrease in BMD. The decrease rate constant of BMD (ke) in each individual was determined as a slope of linear regression of the relationship between time and logarithm of BMD value in each patient during the AI therapy. To compensate for the age-related change in BMD level, we estimated the age-related decrease rate constant of BMD (ke,0) in healthy Japanese postmenopausal women from the literature. AIs decreased BMD with a ke value of -0.0329 yr-1, which was 4.7-fold larger than the ke,0 value of -0.00699 yr-1. No significant difference was detected in the influence on BMD among AIs. Co-administration of BP ameliorated the ke value to -0.0117 yr-1, a value similar to ke,0. The influence of AIs on BMD was quantitatively evaluated by using the decrease rate constant of BMD (ke). The present study also suggests that BPs may be useful to prevent the decrease in BMD induced by AIs.

AB - We retrospectively analyzed the bone mineral density (BMD) of postmenopausal Japanese women taking an aromatase inhibitor (AI), exemestane, anastrozole or letrozole, and calculated the decrease rate constant of BMD in each individual to compare the influence of the three AIs on BMD. We also aimed to evaluate the preventive effect of bisphosphonates (BPs) on the AI-induced decrease in BMD. The decrease rate constant of BMD (ke) in each individual was determined as a slope of linear regression of the relationship between time and logarithm of BMD value in each patient during the AI therapy. To compensate for the age-related change in BMD level, we estimated the age-related decrease rate constant of BMD (ke,0) in healthy Japanese postmenopausal women from the literature. AIs decreased BMD with a ke value of -0.0329 yr-1, which was 4.7-fold larger than the ke,0 value of -0.00699 yr-1. No significant difference was detected in the influence on BMD among AIs. Co-administration of BP ameliorated the ke value to -0.0117 yr-1, a value similar to ke,0. The influence of AIs on BMD was quantitatively evaluated by using the decrease rate constant of BMD (ke). The present study also suggests that BPs may be useful to prevent the decrease in BMD induced by AIs.

KW - Aromatase inhibitor

KW - Bisphosphonate

KW - Bone mineral density

KW - Postmenopausal Japanese population

UR - http://www.scopus.com/inward/record.url?scp=84886392552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886392552&partnerID=8YFLogxK

U2 - 10.2133/dmpk.DMPK-12-NT-095

DO - 10.2133/dmpk.DMPK-12-NT-095

M3 - Article

C2 - 23574887

AN - SCOPUS:84886392552

VL - 28

SP - 446

EP - 450

JO - Drug Metabolism and Pharmacokinetics

JF - Drug Metabolism and Pharmacokinetics

SN - 1347-4367

IS - 5

ER -